People with pulmonary arterial hypertension (PAH) have a distinct immune profile compared with healthy individuals, according to a new…
Articles by Lindsey Shapiro, PhD
The use of the hormone vasopressin successfully stabilized symptoms associated with pulmonary hypertension (PH) in newborns, and avoided the…
The leading causes of death among people with pulmonary hypertension (PH) differ by PH type, a Japanese study…
High scores on a measure known as H2FPEF — which reflect an increased probability of dysfunction of the left ventricle…
Anumana’s electrocardiogram (ECG)-based algorithm for the early detection of pulmonary hypertension (PH) has been designated a breakthrough device by…
To celebrate World Pulmonary Hypertension Day on May 5, Ferrer and the European Pulmonary Hypertension Association (PHA Europe)…
Chiesi Farmaceutici has acquired the worldwide rights to a number of investigational antibodies that may be able to treat…
Longer-term use of Ventavis (iloprost) as an add-on therapy significantly improved blood flow and lowered blood pressure in people…
Infants born extremely premature — at 23 to 25 weeks of pregnancy — are at a high risk of developing…
The Pulmonary Hypertension Association (PHA) will join more than 80 organizations around the world on May 5 to recognize…
Treatment with DehydraTECH-CBD, Lexaria Bioscience’s investigational cannabis-derived treatment for pulmonary hypertension (PH), led to reduced pulmonary artery pressure…
A four-week self-help intervention program — based on principles of cognitive-behavioral therapy (CBT), a type of talk therapy — significantly…